Published in Brain Res on November 14, 1983
Postnatal changes in motoneurone electrotonic coupling studied in the in vitro rat lumbar spinal cord. J Physiol (1991) 1.49
Electrophysiological properties of neonatal rat motoneurones studied in vitro. J Physiol (1986) 1.35
Ionic mechanisms mediating 5-hydroxytryptamine- and noradrenaline-evoked depolarization of adult rat facial motoneurones. J Physiol (1992) 1.15
Inhibitors of calcium buffering depress evoked transmitter release at the squid giant synapse. J Physiol (1985) 1.13
Neuroprotective effect of hydrogen peroxide on an in vitro model of brain ischaemia. Br J Pharmacol (2008) 0.97
Therapeutic potential of targeting hydrogen peroxide metabolism in the treatment of brain ischaemia. Br J Pharmacol (2012) 0.91
An electrophysiological study of the in vitro, perfused brain stem-cerebellum of adult guinea-pig. J Physiol (1988) 0.91
The dependence of motoneurone membrane potential on extracellular ion concentrations studied in isolated rat spinal cord. J Physiol (1988) 0.91
Protective role of hydrogen peroxide in oxygen-deprived dopaminergic neurones of the rat substantia nigra. J Physiol (2005) 0.87
Synaptic physiology of spinal motoneurones of normal and spastic mice: an in vitro study. J Physiol (1986) 0.87
Inhibitory and excitatory neuromodulation by hydrogen peroxide: translating energetics to information. J Physiol (2015) 0.78
Relationship between presynaptic calcium current and postsynaptic potential in squid giant synapse. Biophys J (1981) 5.19
Presynaptic calcium currents in squid giant synapse. Biophys J (1981) 5.07
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
Presynaptic calcium currents and their relation to synaptic transmission: voltage clamp study in squid giant synapse and theoretical model for the calcium gate. Proc Natl Acad Sci U S A (1976) 3.68
Participation by women in behavior analysis. Behav Anal (1983) 2.95
Synaptic transmission in squid giant synapse after potassium conductance blockage with external 3- and 4-aminopyridine. Biophys J (1976) 2.02
Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antiseptic-impregnated urethral catheters (the CATHETER trial). Health Technol Assess (2012) 1.66
Smoking and mental illness. Pharmacol Biochem Behav (2001) 1.63
CRASH trial is based on problematic meta-analysis. BMJ (1999) 1.55
Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med (2001) 1.41
Inferior olive: its role in motor learing. Science (1975) 1.40
Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics (1998) 1.36
Electrophysiological properties of neonatal rat motoneurones studied in vitro. J Physiol (1986) 1.35
Critical thresholds of intracranial pressure and cerebral perfusion pressure related to age in paediatric head injury. J Neurol Neurosurg Psychiatry (2005) 1.28
Insufficient stocking of poisoning antidotes in hospital pharmacies. JAMA (1996) 1.27
A comparison of winged steel needles and Teflon cannulas in maintaining intravenous access during gastrointestinal endoscopy. Gastrointest Endosc (1993) 1.23
Ionic mechanisms underlying the firing properties of rat neonatal motoneurons studied in vitro. Neuroscience (1986) 1.13
Clinical features, autoantibodies and HLA-DR antigens in rheumatoid arthritis. J Rheumatol (1985) 1.08
The role of ultraviolet wavelengths in the mate-choice decisions of female three-spined sticklebacks. J Exp Biol (2005) 1.07
The isolated and perfused brain of the guinea-pig in vitro. Eur J Neurosci (1993) 1.01
Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis. Drugs (1996) 0.99
Physical mapping of the holoprosencephaly critical region in 21q22.3, exclusion of SIM2 as a candidate gene for holoprosencephaly, and mapping of SIM2 to a region of chromosome 21 important for Down syndrome. Am J Hum Genet (1995) 0.97
Sleep-related breathing disorders following discharge from intensive care. Intensive Care Med (2000) 0.92
A model for synaptic transmission. Brain Res Bull (1979) 0.91
Magnetic sources of the M50 response are localized to frontal cortex. Clin Neurophysiol (2008) 0.91
Mathematical modelling and quantitative methods. Food Chem Toxicol (2002) 0.90
Human variability in CYP3A4 metabolism and CYP3A4-related uncertainty factors for risk assessment. Food Chem Toxicol (2003) 0.89
A direct role for c-fos in AP-1-dependent gene transcription. Cell Growth Differ (1990) 0.85
Central airway compression. Anaesthetic and intensive care consequences. Anaesthesia (1997) 0.85
Spaceflight induces changes in the synaptic circuitry of the postnatal developing neocortex. Cereb Cortex (2002) 0.85
Outcome of children requiring intensive care following haematopoietic SCT for primary immunodeficiency and other non-malignant disorders. Bone Marrow Transplant (2011) 0.84
Human variability in xenobiotic metabolism and pathway-related uncertainty factors for chemical risk assessment: a review. Food Chem Toxicol (2005) 0.84
Genetic variants of properdin factor B (Bf) in rheumatoid arthritis. J Rheumatol (1985) 0.84
Profile of human macrophage transcripts: insights into macrophage biology and identification of novel chemokines. J Leukoc Biol (1998) 0.83
The influence of age on the pharmacokinetics of paracetamol [proceedings]. Br J Clin Pharmacol (1979) 0.83
Cyclic AMP- and phorbol ester-induced transcriptional activation are mediated by the same enhancer element in the human vasoactive intestinal peptide gene. J Biol Chem (1991) 0.83
Acute calcific periarthritis associated with transient hypocalcaemia secondary to hypoparathyroidism. Br J Rheumatol (1983) 0.82
Human variability in glucuronidation in relation to uncertainty factors for risk assessment. Food Chem Toxicol (2001) 0.82
Molecular analysis and breakpoint definition of a set of human chromosome 21 somatic cell hybrids. Somat Cell Mol Genet (1995) 0.81
Uncertainty factors for chemical risk assessment. human variability in the pharmacokinetics of CYP1A2 probe substrates. Food Chem Toxicol (2001) 0.80
Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate? Food Chem Toxicol (2002) 0.79
A study of two diuretic/potassium combinations in heart failure. Postgrad Med J (1985) 0.79
An analysis of the need for an additional uncertainty factor for infants and children. Regul Toxicol Pharmacol (2000) 0.78
Transmission in the squid giant synapse: a model based on voltage clamp studies. J Physiol (Paris) (1980) 0.78
Polymorphic CYP2C19 and N-acetylation: human variability in kinetics and pathway-related uncertainty factors. Food Chem Toxicol (2003) 0.77
Further studies on depolarization release coupling in squid giant synapse. Adv Exp Med Biol (1987) 0.77
Pseudomonas arthritis treated with parenteral and intra-articular ceftazidime. Ann Rheum Dis (1985) 0.77
"It could probably help someone else but not me": a feasibility study of a snack programme offered to meals on wheels clients. J Nutr Health Aging (2013) 0.76
Interactive effects of fluoride and aluminum uptake and accumulation in bones of rabbits administered both agents in their drinking water. J Toxicol Environ Health (1995) 0.76
Intravenous azithromycin as salvage therapy in a patient with Legionnaire's disease. Thorax (1994) 0.75
Comment: Ciprofloxacin excretion into breast milk. DICP (1990) 0.75
Meningococcal disease in healthcare workers. Long term effects and costs are unclear. BMJ (2000) 0.75
Radiopharmaceuticals and lactation. J Hum Lact (1990) 0.75
Antiinfectives in breastmilk. Part II: Sulfonamides, tetracyclines, macrolides, aminoglycosides and antimalarials. J Hum Lact (1992) 0.75
Discharge delays in a British NHS rehabilitation unit. Clin Rehabil (2000) 0.75
Human variability for metabolic pathways with limited data (CYP2A6, CYP2C9, CYP2E1, ADH, esterases, glycine and sulphate conjugation). Food Chem Toxicol (2004) 0.75
Antiinfectives in breastmilk. Part I: Penicillins and cephalosporins. J Hum Lact (1992) 0.75
Accessing packaged food and beverages in hospital. Exploring experiences of patients and staff. Appetite (2012) 0.75
Alternate day steroids in renal transplant patients. Proc Clin Dial Transplant Forum (1977) 0.75
Quantification of secondary CPP insult severity in paediatric head injured patients using a pressure-time index. Acta Neurochir Suppl (2005) 0.75
Antiarrhythmics in breastfeeding. J Hum Lact (1994) 0.75
Erratum to: Moclobemide: An update of its pharmacological properties and therapeutic use. Drugs (1996) 0.75
Human variability in the renal elimination of foreign compounds and renal excretion-related uncertainty factors for risk assessment. Food Chem Toxicol (2004) 0.75
Phonological patterns in a case of aphasia. Lang Speech (1976) 0.75
Oral cancer. Br Dent J (1996) 0.75
Evaluation of a pilot volunteer feeding assistance program: influences on the dietary intakes of elderly hospitalised patients and lessons learnt. J Nutr Health Aging (2015) 0.75
Bioactivation of the carcinogen 11-methoxy-16, 17-dihydro-15H-cyclopenta[a]phenanthrene. Mutat Res (2000) 0.75
Social problem-solving interventions in medium secure settings for women. Med Sci Law (2011) 0.75
The galactopharmacopedia. Recreational drug use in the breastfeeding mother. Part 2: Licit drugs. J Hum Lact (1990) 0.75
Influenza: an outbreak in a UK respiratory centre. Br J Nurs (2013) 0.75
Antiinfectives in breastmilk. Part III: Antituberculars, quinolones and urinary germicides. J Hum Lact (1993) 0.75
Operative morbidity among 40 living kidney donors. J Surg Res (1972) 0.75
The use of surrogate endpoints to assess potential toxicity in humans. Toxicol Lett (2001) 0.75